Richard S. Bowles III is Exe VP&Chief Ethics & ComplOff at Merck & Co. Inc. (MRK). They have made 5 open-market trades across 1 company since 2010, most recently 2012-05-10.
CIK 0001475384
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MRK | 73,540 | $10.7M |
Shares reported on the most recent Form 4, priced at the 2012-05-10 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MRK | SELL | 2012-05-10 | 2012-05-10 | $38.50 | $1.1M | -2.6% | +0.9% | +0.9% |
| MRK | SELL | 2012-02-17 | 2012-02-21 | $38.78 | $1.6M | -2.6% | +0.9% | +0.9% |
| MRK | SELL | 2011-11-11 | 2011-11-14 | $35.90 | $1.1M | -2.6% | +0.9% | +0.9% |
| MRK | SELL | 2011-05-04 | 2011-05-06 | $36.56 | $1.1M | -2.6% | +0.9% | +0.9% |
| MRK | SELL | 2010-02-24 | 2010-02-24 | $37.00 | $3.0M | -2.6% | +0.9% | +0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.